Atezolizumab vs Mirvetuximab Soravtansine

## Atezolizumab vs Mirvetuximab Soravtansine: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Mirvetuximab Soravtansine**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Mirvetuximab Soravtansine — N/A.

## Chemical Properties

**Type**: Atezolizumab — Antibody; Mirvetuximab Soravtansine — Antibody drug conjugate.